FROM THE NEWS FEED
UC San Francisco researchers are weighing in on one of the biggest challenges in psychedelic science, arguing that clinical trials need more convincing placebo treatments to better measure the drugs' true effects.
Continue to the original publication for the complete article.
KEEP EXPLORING
A new study led by researchers at the University of California, Santa Cruz, reveals how psilocybin, the psychoactive ...
First synthesized in a laboratory in 1938 by the Swiss chemist Albert Hofmann, lysergic acid diethylamide, better kno...
An imaging study in humans led by Tel Aviv University's Institute for Psychedelic Research, in collaboration with TAU...
Psychedelics are no magic wand or silver bullet. However, in partnership with talk therapy, physical therapy, and oth...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
Hereβs what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
There are many factors that can affect your journey, from set and setting to substance and dosage. At Psychedelic Pas...
Personal growth is a lifelong process. We've heard from so many people that, after years of other avenues, a psychede...
Again and again, we find that psychedelics can be the missing element that help people to heal and recover from past ...